AVIR
Asset Logo

Atea Pharmaceuticals Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-22.02%
Annual Growth

4 years average annual growth

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The Company is engaged in is conducting a Phase 3 clinical trial evaluating bemnifosbuvir for the treatment of Coronavirus disease 2019 (COVID-19). It is also conducting a Phase 2 clinical trial evaluating the combination of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV). The bemnifosbuvir (AT-527), is an investigational, novel, orally administered guanosine nucleotide analog polymerase inhibitor that combines a unique nucleotide scaffold with novel double prodrugs for the intended purpose of inhibiting the enzymes central to viral replication. SUNRISE-3 is designed to evaluate bemnifosbuvir as monotherapy, but it is also exploring the effect of combination therapy in a smaller sub-set of patients.

📈 Performance

Price History*

-89.52%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$3.25

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in AVIR

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

0 days

💵 Average investment amount

$189

Last time a customer invested in AVIR

900 days
AVIR investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in AVIR also invest in...

Columbia Banking System Inc

COLB

🙌 Performance (5Yr p.a)

-4.29%

📊 Share price

$30.67 USD
Find Out More

🙌 Performance (5Yr p.a)

25.13%

📊 Share price

$102.76 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-3.20%

📊 Share price

$19.98 USD

🙌 Performance (5Yr p.a)

-2.25%

📊 Share price

$10.78 USD

🙌 Performance (5Yr p.a)

-0.68%

📊 Share price

$7.86 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-4.26%

📊 Share price

$11.86 USD
Compare
Add to watchlist